The flu vaccine is its first using mRNA technology for influenza.
The US Food and Drug Administration has refused to accept an application from Moderna to review its first mRNA seasonal flu vaccine, the company said Tuesday, in another setback for the technology ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results